Amgen Inc (NASDAQ:AMGN)., a leading biopharmaceutical company with a market capitalization of $155 billion, is at a pivotal juncture as it navigates the competitive landscape of innovative ...

Cantor Fitzgerald, in particular, has expressed high conviction in the obesity program, suggesting that MariTide could be worth approximately $140 per share ... on emerging trends in personalized ...

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...